Starting on 19 September 2022, the very first ImmunOctoberfest conference took place in Raitenhaslach, Germany, bringing together scientists from all over the world to discuss ‘bridging innovation and translation in T cell immunotherapy’.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Delgoffe, G. M. Immunology 166, 425–428 (2022).
Hashimoto, M. et al. Nature 610, 173–181 (2022).
Codarri Deak, L. et al. Nature 610, 161–172 (2022).
Tsui, C. et al. Nature 609, 354–360 (2022).
Gearty, S. V. et al. Nature 602, 156–161 (2022).
Pawlak, M. et al. Immunity 55, 1663–1679.e1666 (2022).
Schnell, A. et al. Cell 184, 6281–6298.e6223 (2021).
Prinzing, B. et al. Sci. Transl. Med. 13, eabh0272 (2021).
Yu, Y. R. et al. Nat. Immunol. 21, 1540–1551 (2020).
Guo, Y. et al. Nat. Immunol. 22, 746–756 (2021).
Hochrein, S. M. et al. Cell Metab 34, 516–532.e511 (2022).
Zandhuis, N. D., Nicolet, B. P. & Wolkers, M. C. Front Immunol 12, 717324 (2021).
Dudek, M. et al. Nature 592, 444–449 (2021).
Hiltensperger, M. et al. Nat. Immunol. 22, 880–892 (2021).
Lin, C. H. et al. J. Exp. Med. 218, e20210021 (2021).
von Hoesslin, M. et al. Sci. Immunol. 7, eabp9553 (2022).
Parga-Vidal, L. et al. Eur. J. Immunol. 52, 1095–1111 (2022).
Acknowledgements
We would like to express our thanks to the generous sponsors that enabled the meeting: BioVariance, BioLegend, Boehringer Ingelheim Foundation, German Research Foundation (DFG), ElevateBio, IMGM, Miltenyi Biotec, OnkoMedeor Diagnostic MVZ, Pieris Pharmaceuticals, Pharmigon, Roche, Takara, TMICC and the Technical University of Munich.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Schulz, A.M., Zebley, C.C., Youngblood, B. et al. Tapping the keg of discovery to advance T cell therapy. Nat Immunol 24, 213–215 (2023). https://doi.org/10.1038/s41590-022-01401-0
Published:
Issue date:
DOI: https://doi.org/10.1038/s41590-022-01401-0
